ClinConnect ClinConnect Logo
Search / Trial NCT01131130

Feasibility of a New Silicone Hydrogel Lens

Launched by BAUSCH & LOMB INCORPORATED · May 25, 2010

Trial Information

Current as of May 22, 2025

Completed

Keywords

Contact Lens

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Participants must have clear central corneas and be free of any anterior segment disorders.
  • Participants must be adapted wearers of soft contact lenses, wear a lens in each eye, and each lens must be of the same manufacture and brand.
  • Participants must be myopic and require lens correction from -0.75 D to - 4.75D in each eye.
  • Exclusion Criteria:
  • Participants who have worn gas permeable (GP) contact lenses within the last 30 days or who have worn polymethylmethacrylate (PMMA) lenses within the last three months.
  • Participants with any systemic disease affecting ocular health.
  • Participants using any systemic or topical medications that will, in the Investigator's opinion, affect ocular physiology or lens performance.
  • Participants with an active ocular disease or are using any ocular medication.
  • Participants who have had any corneal surgery (eg, refractive surgery).
  • Participants who are allergic to any component in the study care products.

About Bausch & Lomb Incorporated

Bausch & Lomb Incorporated is a leading global eye health company dedicated to advancing the vision and well-being of individuals through innovative products and solutions. With a rich history spanning over 160 years, Bausch & Lomb specializes in the development, manufacturing, and marketing of a comprehensive range of eye care products, including contact lenses, lens care solutions, and pharmaceuticals for various ocular conditions. The company is committed to rigorous clinical research and trials to ensure the safety and efficacy of its offerings, striving to enhance patient outcomes and improve quality of life for those with vision-related challenges.

Locations

Rochester, New York, United States

Patients applied

0 patients applied

Trial Officials

Gerard Carains, MCOptom, PhD

Study Director

Bausch & Lomb Incorporated

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials